-
Infographic of July is Cord Blood Awareness Month Available on Business Wire's Website
Infographic of July is Cord Blood Awareness Month Available on Business Wire's Website
Share
MINNEAPOLIS--(BUSINESS WIRE)--An infographic is available on Business Wire's website of July is Cord Blood Awareness Month. The infographic is provided by Be The Match BioTherapies.
Contacts
Phyllis Grabot, phyllis@clarityqst.com, 805.341.7269
More News From Be The Match BioTherapies
NMDP BioTherapies and the NMDP BioTherapies Cord Blood Bank Alliance Introduce Optimal Cord Blood Units for Manufacture of NK Cell Therapies And Other Cord Derived Cell Therapies
MINNEAPOLIS--(BUSINESS WIRE)--NMDP BioTherapiesSM (formerly known as the Be The Match BioTherapies), a leader in cell and gene therapy development support, and the NMDP BioTherapies Cord Blood Bank Alliance (CBBA), a partnership between NMDP BioTherapies and nine public cord blood banks, are making available pre-identified cord blood units that are optimized for manufacture of cord-derived cell therapies, and in particular cord-derived NK cell therapies. The identification and supply of these u...
NMDP BioTherapies To Present Data at ISCT 2024 on the Stability of Infectious Disease Marker Analytes During Donor Qualification for Allogeneic Cell Therapies
MINNEAPOLIS--(BUSINESS WIRE)--NMDP BioTherapies℠ (formerly known as Be The Match BioTherapies), a leader in cell and gene therapy development support, will present a poster at this year’s International Society for Cell & Gene Therapy annual meeting in Vancouver, Canada (ISCT 2024 ) sharing results of a study of the impacts of delayed whole blood processing on the stability of infectious disease marker analytes during donor qualification for allogeneic cell therapies. Results of the study in...
CIBMTR® Launches Rapid Clinical Site Selection and Activation, Resulting in Faster Trial Enrollment for Cell and Gene Therapy Trials
MINNEAPOLIS--(BUSINESS WIRE)--NMDP BioTherapies announced today that CIBMTR CRO Services now offers a rapid clinical site selection and activation service, resulting in faster trial enrollment for cell and gene therapy (CGT) trials. By leveraging data from its 675,000+ patient clinical outcomes database, CIBMTR can quickly identify, vet and select transplant centers based on patient population, diversity and competing trials. “At hand-off to our dedicated site startup team, we leverage our deep...
